Guardian Capital LP Gilead Sciences, Inc. Transaction History

Guardian Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $329,552 - $363,768	-5,272 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $326,178 - $365,771	5,272 New	5,272 $356,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $489,193 - $596,380	-6,716 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $2,774 - $3,257	39 Added 0.58%	6,716 $481,000
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $481,478 - $570,683	6,677	6,677 $541,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.